GS2: Health
- Covaxin price reduced to ₹400/dose for States(TH) This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at ₹150 per dose.
- Is the government committed to vaccine equity?(TH) The government has not really thought through the vaccination and pricing policy
- ‘Not enough vaccines to inoculate those above 18 years’(TH) Manufacturers requested, clarity on stock availability in a couple of days, says Delhi Health Minister
GS2: International Developments
- ‘Vaccine Maitri may have to wait till July’(TH) ‘Today, our needs are far greater, and all our partners understand that in this context’
